Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

28. Oktober 2025 06:10 ET | Quelle: PL BioScience GmbH

PL BioScience Announces new Board Member Ole Henrik Bang-Andreasen

AACHEN, Germany, Oct. 28, 2025 (GLOBE NEWSWIRE) -- PL BioScience GmbH, a German life science company specializing in the production and development of Human Platelet Lysate (HPL) for cell expansion...
31. Juli 2025 04:00 ET | Quelle: PL BioScience GmbH

PL BioScience Announces Major Site Expansion

New 1,200 m² facility in Aachen expands headquarters to support company growth and scale Human Platelet Lysate productionSite provides the world’s largest HPL output with 20,000L annual capacity and a...
08. Mai 2025 08:00 ET | Quelle: PL BioScience GmbH

PL BioScience Raises the Bar in Cell Culture Technology with First Artificial Human Platelet Lysate Worldwide

Worldwide first artificial Human Platelet Lysate (HPL) solution – a key ingredient for the research & production of cell-based pharmaceuticals – developed based on artificial platelet technology...
30. April 2025 06:06 ET | Quelle: PL BioScience GmbH

PL BioScience Launches World’s Only Patented Gamma-irradiated Human Platelet Lysate

New high-quality cell growth supplement for cell manufacturing applications including in regenerative medicine and cell therapiesHuman Platelet Lysate (HPL) offers a safer and sustainable alternative...